Metsera, Inc. aims to raise $275 million in an IPO to fund its clinical-stage biopharma programs targeting obesity and ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Veru's enobosarm showed significant body composition benefits in Phase 2b trials with semaglutide. Extension study results are due in April 2025.

Immunoprecise shares closed higher on Wednesday after the company announced it developed a new class of GLP-1 therapies.

In November 2023 Colombia imposed a tax on highly processed foods and drinks. Authorities in Brazil, Canada and Peru have ...

Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight ...

Looking for a reliable way to lose weight?? Meet Mounjaro UAE, the latest injectable medication that’s making waves among ...

After winning first place in a national grant program, the Town of Chapel Hill is set to jump-start a youth bicycle education ...

I part French Vermouth i part Italian Vermouth 1 part Orange Juice 6 parts Gold Label Rum Shake well with cracked ice. Decorate with a twist of orange peel. Some recipes call for gin instead of rum ...

New research has found that UK bowel cancer death rates are forecast to rise by a third amongst young British adults – with obesity and binge drinking thought ... The Bristol Stool Chart can be a ...

Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.